T. Rowe Price Investment Management’s Rapport Therapeutics RAPP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$6.98M	Sell	613,819 -938,106	-60%	-$10.7M	﹤0.01%	571
2025 Q1	$15.6M	Sell	1,551,925 -85,006	-5%	-$853K	0.01%	538
2024 Q4	$29M	Sell	1,636,931 -90,180	-5%	-$1.6M	0.02%	479
2024 Q3	$35.4M	Buy	1,727,111 +191,960	+13%	+$3.93M	0.02%	457
2024 Q2	$35.7M	Buy	+1,535,151	New	+$35.7M	0.02%	442